Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Loïc Martin

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Virology|October 7, 2008
A simple one-step method for the preparation of HIV-1 envelope glycoprotein immunogens based on a CD4 mimic peptideGrégoire Martin, Yide Sun, Bernadette Heyd, et al.
Optics Letters|March 27, 2012
Mueller matrix polarimetry for improved liver fibrosis diagnosisMatthieu Dubreuil, Philippe Babilotte, Loïc Martin, et al.
Journal of Virology|November 16, 2012
Straightforward selection of broadly neutralizing single-domain antibodies targeting the conserved CD4 and coreceptor binding sites of HIV-1 gp120Julie Matz, Pascal Kessler, Jérôme Bouchet, et al.
Computational and Structural Biotechnology Journal|May 27, 2026
Optimized Quantitative Bacterial Two-Hybrid (qB2H) for Protein-Protein Interaction AssessmentAntoine Guyot, Emma Maillard, Kelly Ferreira-Pinto, et al.
Structure (London, England : 1993)|October 24, 2017
Targeting the Late Stage of HIV-1 Entry for Antibody-Dependent Cellular Cytotoxicity: Structural Basis for Env Epitopes in the C11 RegionWilliam D Tolbert, Neelakshi Gohain, Nirmin Alsahafi, et al.
Structure (London, England : 1993)|May 28, 2013
Structural basis for highly effective HIV-1 neutralization by CD4-mimetic miniproteins revealed by 1.5 Å cocrystal structure of gp120 and M48U1Priyamvada Acharya, Timothy S Luongo, Mark K Louder, et al.
Journal of Virology|December 21, 2018
Evolution of the Envelope Glycoprotein of HIV-1 Clade B toward Higher Infectious Properties over the Course of the EpidemicMélanie Bouvin-Pley, Maxime Beretta, Alain Moreau, et al.
International Journal of Pharmaceutics|March 19, 2013
Note on the formulation of thermosensitive and mucoadhesive vaginal hydrogels containing the miniCD4 M48U1 as anti-HIV-1 microbicideKawthar Bouchemal, Justyna Frelichowska, Loïc Martin, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 30, 2011
Quaternary structures of HIV Env immunogen exhibit conformational vicissitudes and interface diminution elicited by ligand bindingCarlos G Moscoso, Yide Sun, Selina Poon, et al.
Scientific Reports|February 2, 2017
M48U1 and Tenofovir combination synergistically inhibits HIV infection in activated PBMCs and human cervicovaginal histoculturesGiuseppina Musumeci, Isabella Bon, David Lembo, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Virology|October 7, 2008
A simple one-step method for the preparation of HIV-1 envelope glycoprotein immunogens based on a CD4 mimic peptideGrégoire Martin, Yide Sun, Bernadette Heyd, et al.
Optics Letters|March 27, 2012
Mueller matrix polarimetry for improved liver fibrosis diagnosisMatthieu Dubreuil, Philippe Babilotte, Loïc Martin, et al.
Journal of Virology|November 16, 2012
Straightforward selection of broadly neutralizing single-domain antibodies targeting the conserved CD4 and coreceptor binding sites of HIV-1 gp120Julie Matz, Pascal Kessler, Jérôme Bouchet, et al.
Computational and Structural Biotechnology Journal|May 27, 2026
Optimized Quantitative Bacterial Two-Hybrid (qB2H) for Protein-Protein Interaction AssessmentAntoine Guyot, Emma Maillard, Kelly Ferreira-Pinto, et al.
Structure (London, England : 1993)|October 24, 2017
Targeting the Late Stage of HIV-1 Entry for Antibody-Dependent Cellular Cytotoxicity: Structural Basis for Env Epitopes in the C11 RegionWilliam D Tolbert, Neelakshi Gohain, Nirmin Alsahafi, et al.
Structure (London, England : 1993)|May 28, 2013
Structural basis for highly effective HIV-1 neutralization by CD4-mimetic miniproteins revealed by 1.5 Å cocrystal structure of gp120 and M48U1Priyamvada Acharya, Timothy S Luongo, Mark K Louder, et al.
Journal of Virology|December 21, 2018
Evolution of the Envelope Glycoprotein of HIV-1 Clade B toward Higher Infectious Properties over the Course of the EpidemicMélanie Bouvin-Pley, Maxime Beretta, Alain Moreau, et al.
International Journal of Pharmaceutics|March 19, 2013
Note on the formulation of thermosensitive and mucoadhesive vaginal hydrogels containing the miniCD4 M48U1 as anti-HIV-1 microbicideKawthar Bouchemal, Justyna Frelichowska, Loïc Martin, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 30, 2011
Quaternary structures of HIV Env immunogen exhibit conformational vicissitudes and interface diminution elicited by ligand bindingCarlos G Moscoso, Yide Sun, Selina Poon, et al.
Scientific Reports|February 2, 2017
M48U1 and Tenofovir combination synergistically inhibits HIV infection in activated PBMCs and human cervicovaginal histoculturesGiuseppina Musumeci, Isabella Bon, David Lembo, et al.
Pageof 5